Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Sutter

Showing results (11-20 of 179) with videos related to

Pageof 18
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|April 29, 2004
Construction and isolation of recombinant MVACaroline Staib, Ingo Drexler, Gerd Sutter
The Journal of General Virology|June 17, 2005
Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus AnkaraCaroline Staib, Sigrid Kisling, Volker Erfle, et al.
Biotechniques|April 22, 2003
Improved host range selection for recombinant modified vaccinia virus AnkaraCaroline Staib, Marianne Löwel, Volker Erfle, et al.
Journal of Virological Methods|October 9, 2002
Generation of recombinant fowlpox virus using the non-essential F11L orthologue as insertion site and a rapid transient selection strategyDenise Boulanger, Robert Baier, Volker Erfle, et al.
The Journal of General Virology|May 29, 2003
Comparison of virus production in chicken embryo fibroblasts infected with the WR, IHD-J and MVA strains of vaccinia virus: IHD-J is most efficient in trans-Golgi network wrapping and extracellular enveloped virus releaseAndrea Meiser, Denise Boulanger, Gerd Sutter, et al.
Berliner Und Munchener Tierarztliche Wochenschrift|December 25, 2015
[Modified vaccinia virus ankara (MVA)--development as recombinant vaccine and prospects for use in veterinary medicine]Asisa Volz, Robert Fux, Martin C Langenmayer, et al.
The Journal of General Virology|September 12, 2006
Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus AnkaraCaroline Staib, Yasemin Suezer, Sigrid Kisling, et al.
Journal of Virology|July 11, 2014
Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus AnkaraAsisa Volz, Martin Langenmayer, Sylvia Jany, et al.
Virology|March 21, 2008
The highly conserved orthopoxvirus 68k ankyrin-like protein is part of a cellular SCF ubiquitin ligase complexKarin M Sperling, Astrid Schwantes, Barbara S Schnierle, et al.
Journal of Virology|August 19, 2007
Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccinesGeorg Gasteiger, Wolfgang Kastenmuller, Ronny Ljapoci, et al.
Pageof 18

Showing results (11-20 of 179) with videos related to

Sort By:
Pageof 18
Methods in Molecular Biology (Clifton, N.J.)|April 29, 2004
Construction and isolation of recombinant MVACaroline Staib, Ingo Drexler, Gerd Sutter
The Journal of General Virology|June 17, 2005
Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus AnkaraCaroline Staib, Sigrid Kisling, Volker Erfle, et al.
Biotechniques|April 22, 2003
Improved host range selection for recombinant modified vaccinia virus AnkaraCaroline Staib, Marianne Löwel, Volker Erfle, et al.
Journal of Virological Methods|October 9, 2002
Generation of recombinant fowlpox virus using the non-essential F11L orthologue as insertion site and a rapid transient selection strategyDenise Boulanger, Robert Baier, Volker Erfle, et al.
The Journal of General Virology|May 29, 2003
Comparison of virus production in chicken embryo fibroblasts infected with the WR, IHD-J and MVA strains of vaccinia virus: IHD-J is most efficient in trans-Golgi network wrapping and extracellular enveloped virus releaseAndrea Meiser, Denise Boulanger, Gerd Sutter, et al.
Berliner Und Munchener Tierarztliche Wochenschrift|December 25, 2015
[Modified vaccinia virus ankara (MVA)--development as recombinant vaccine and prospects for use in veterinary medicine]Asisa Volz, Robert Fux, Martin C Langenmayer, et al.
The Journal of General Virology|September 12, 2006
Short-term, but not post-exposure, protection against lethal orthopoxvirus challenge after immunization with modified vaccinia virus AnkaraCaroline Staib, Yasemin Suezer, Sigrid Kisling, et al.
Journal of Virology|July 11, 2014
Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus AnkaraAsisa Volz, Martin Langenmayer, Sylvia Jany, et al.
Virology|March 21, 2008
The highly conserved orthopoxvirus 68k ankyrin-like protein is part of a cellular SCF ubiquitin ligase complexKarin M Sperling, Astrid Schwantes, Barbara S Schnierle, et al.
Journal of Virology|August 19, 2007
Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccinesGeorg Gasteiger, Wolfgang Kastenmuller, Ronny Ljapoci, et al.
Pageof 18